PhaseBio Pharmaceuticals Inc Uncategorized Contracts & Agreements
8 Contracts & Agreements
- First Amended Combined Disclosure Statement and Chapter 11 Plan (Filed With SEC on July 12, 2024)
- Form of RSU Grant Notice and Award Agreement for 2022 Inducement Plan (Filed With SEC on May 16, 2022)
- Form of RSU Grant Notice and Award Agreement for 2022 Inducement Plan (Filed With SEC on March 24, 2022)
- Co-Development Agreement, dated January 9, 2020, by and between PhaseBio Pharmaceuticals, Inc. and SFJ Pharmaceuticals X, Ltd (Filed With SEC on March 30, 2020)
- Form of Program Transfer Agreement by and between PhaseBio Pharmaceuticals Inc. and SFJ Pharmaceuticals X. Ltd (Filed With SEC on March 30, 2020)
- Offer Letter, dated as of March 30, 2016, by and between the Registrant and John Lee, M.D., Ph.D (Filed With SEC on September 21, 2018)
- Offer Letter, dated as of March 13, 2016, by and between the Registrant and John Sharp (Filed With SEC on September 21, 2018)
- Offer Letter, dated as of November 19, 2012, by and between the Registrant and Jonathan P. Mow, as amended to date (Filed With SEC on September 21, 2018)
